Ultrasound Guided Erector Spinae Plane Block Versus Quadratus Lumborum Block in Laparoscopic Cholecystectomy

NCT ID: NCT04845711

Last Updated: 2021-04-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-01

Study Completion Date

2021-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to compare between the efficacy of ultrasound guided erector spinae plane block and ultrasound guided quadratus lumborum block in managing acute postoperative pain in patients undergoing laparoscopic cholecystectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Cholecystectomy Postoperative Analgesia Erector Spinae Plane Block Quadratus Lumborum Block

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Patients and medical personnel collecting data and conducting follow-up will be blinded to the group of the patient. All blocks will be performed by one anesthesiologist who will not participate in data collection or analysis.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

patients will receive general anesthesia only.

Group Type PLACEBO_COMPARATOR

Control group

Intervention Type OTHER

patients will receive general anesthesia only.

Erector spinae plane block group

patients will receive general anesthesia and bilateral ultrasound guided erector spinae plane block (20ml Bupivacaine 0.25%)

Group Type EXPERIMENTAL

Erector spinae plane block group

Intervention Type PROCEDURE

patients will receive general anesthesia and bilateral ultrasound guided erector spinae plane block (20ml Bupivacaine 0.25%)

Quadratus lumborum block group

patients will receive general anesthesia and bilateral ultrasound guided quadratus lumborum block (20 ml Bupivacaine 0.25%)

Group Type EXPERIMENTAL

Quadratus lumborum block group

Intervention Type PROCEDURE

patients will receive general anesthesia and bilateral ultrasound guided quadratus lumborum block (20 ml Bupivacaine 0.25%)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control group

patients will receive general anesthesia only.

Intervention Type OTHER

Erector spinae plane block group

patients will receive general anesthesia and bilateral ultrasound guided erector spinae plane block (20ml Bupivacaine 0.25%)

Intervention Type PROCEDURE

Quadratus lumborum block group

patients will receive general anesthesia and bilateral ultrasound guided quadratus lumborum block (20 ml Bupivacaine 0.25%)

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Group C group ESPB group QLB

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 21-65 years
* both genders
* American Society of Anesthesiology (ASA) class I-II
* Undergoing elective laparoscopic cholecystectomy

Exclusion Criteria

* Patient refusal.
* Coagulopathy.
* History of allergy to local anaesthetic.
* History of liver or renal pathology affecting drug elimination
* Mental dysfunction or cognitive disorders.
* Use of medication such as gabapentin-pregabalin that could affect pain perception.
* Body Mass Index \> 40 kg/m2.
Minimum Eligible Age

21 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tanta University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mai Elsaid Hamada

Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mai E Hamada, MBBCH

Role: PRINCIPAL_INVESTIGATOR

Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mai E Hamada, MBBCH

Role: CONTACT

00201285851295

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

34503/2/21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Comparison of ESP Block and STAP Plane Block
NCT06663449 NOT_YET_RECRUITING NA